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Antibiotic resistance often evolves by mutations at conserved sites in essential
genes, resulting in parallel molecular evolution between divergent bacterial
strains and species. Whether these resistance mutations are having parallel
effects on fitness across bacterial taxa, however, is unclear. This is an important
point to address, because the fitness effects of resistance mutations play a key
role in the spread and maintenance of resistance in pathogen populations.
We address this idea by measuring the fitness effect of a collection of rifampi-
cin resistance mutations in the b subunit of RNA polymerase (rpoB) across
eight strains that span the diversity of the genus Pseudomonas. We find that
almost 50% of rpoB mutations have background-dependent fitness costs,
demonstrating that epistatic interactions between rpoB and the rest of the
genome are common. Moreover, epistasis is typically strong, and it is the domi-
nant genetic determinant of the cost of resistance mutations. To investigate
the functional basis of epistasis, and because rpoB plays a central role in
transcription, we measured the effects of common rpoB mutations on tran-
scriptional efficiency across three strains of Pseudomonas. Transcriptional
efficiency correlates strongly to fitness across strains, and epistasis arises
because individual rpoB mutations have differential effects on transcriptional
efficiency in different genetic backgrounds.1. Background
Antibiotic resistance is associated with pleiotropic costs that are expressed in terms
of reduced competitive fitness in the absence of antibiotics [1–3]. Fitness costs play a
key role in the dynamics of resistance as they generate selection against resistance in
antibiotic-free conditions, such as when antibiotic use is discontinued, or during
transmission between hosts. Understanding the factors that govern the cost of resist-
ance is therefore crucial for predicting when resistance will persist in pathogen
populations. Put simply, the larger the cost associated with resistance, the less
likely the persistence of resistance in bacterial populations over the long term.
Most antibiotics target highly conserved domains in proteins that play
pivotal roles in cell biology, such as DNA replication, cell-wall assembly and
protein synthesis [4]. The most direct mechanism for bacteria to evolve resist-
ance to antibiotics is by altering the structure of these targets [5]. Because the
target sites of antibiotics are highly conserved, target site mutations show a
strong tendency to evolve in parallel across species of bacteria [6–8]. This
parallel molecular evolution implies that these mutations have some similar
phenotypic effects in these differing bacterial species, in that these mutations
increase resistance to antibiotics. However, the extent to which the fitness
costs of resistance mutations are conserved across genetic backgrounds remains




2epistatic effects on fitness in bacteria [9–12], suggesting that
genetic background could play a key role in shaping the
cost of resistance across species.
In this paper, we investigate the influence of genetic back-
ground on the fitness cost of antibiotic resistance, using a
collection of rifampicin-resistant mutants from the genus
Pseudomonas as a model system [7]. One advantage of work-
ing with Pseudomonas is that the genus is highly diverse, and
yet it is still possible to culture most strains under a common
set of laboratory conditions [13,14], making it possible to
obtain equivalent measures of fitness in different species or
strains of bacteria. Rifampicin is an antibiotic which binds
to a highly conserved domain of RNA polymerase, prevent-
ing RNA-transcript elongation. Resistance to rifampicin
evolves by mutations in rpoB that alter the structure of the
rifampicin binding pocket. The fitness cost of rifampicin
resistance has been measured across a wide range of bacteria,
including Escherichia coli [15], Salmonella typhymurium [6],
Pseudomonas aeruginosa [16], Mycobacterium tuberculosis [17]
and Staphylococcus aureus [18]. However, previous studies
have measured fitness using a range of techniques and under
different environmental conditions [3,19]. As these variables
can affect the estimate of the cost of resistance, it is questiona-
ble to solely rely on comparing fitness cost estimates from
different studies.
To measure the overall contribution of genetic background
to the cost of resistance, we estimated the competitive fitness of
a collection of mutations across eight strains that span the
diversity of Pseudomonas. We then did two further analyses to
try to explain why certain mutations vary in their fitness effects
between genetic backgrounds. First, we use comparative
methods to test whether the effects of a mutation are more con-
served between closely related strains. If genetic background is
a significant but relatively minor determinant of the cost of a
mutation, we would predict a greater probability of differing
fitness effects with increasing genetic distance. Second, rifam-
picin resistance mutations are known to have a range of
effects on transcription [15], and previous work has shown
that the fitness effects of rifampicin resistance correlate with
reductions in transcriptional efficiency [15,20]. Genetic back-
ground could influence the fitness effects of rifampicin
resistance mutations by modulating the effect of altered RNA
polymerase on transcriptional efficiency or by altering the
strength of the correlation between transcriptional efficiency
and fitness. In other words, genetic background can influence
the fitness effects of mutations by altering the relationship
between genotype and phenotype, or the relationship between
phenotype and fitness. To address this issue, we used an
inducible reporter construct to measure the transcriptional effi-
ciency of a subset of rifampicin resistance mutations across
three strains of Pseudomonas.2. Material and methods
(a) Strains and culture conditions
Eight strains of bacteria from the genus Pseudomonas were
used: Pseudomonas aeruginosa PAO1, P. stutzeri ATCC17588,
P. mendocina CCUG7181, P fulva CCUG12573, P. putida KT2440,
P. protegens PF5, P. fluorescens PF01 and P. fluorescens SBW25.
Prior to experimentation, all strains were stored at 2808C in 25%
glycerol. All culturing was performed at 308C with constant
shaking at 200 r.p.m., in King’s B (KB) medium.(b) Isolation of rifampicin-resistant mutants
Rifampicin-resistant mutants were obtained from Vogwill et al. [7]
where they were isolated by fluctuation tests on rifampicin agar.
Briefly, for each strain, an overnight culture was diluted 1 million-
fold and used to found 480 parallel cultures. These were grown
for 48 h before being plated on agar containing either 30 or
60 mg ml21 of rifampicin. After 48 h, mutants were isolated from
93 independent cultures and frozen in 25% glycerol at 2808C. We
then sequenced the two regions of rpoB that can result in high-
level rifampicin resistance. A single example of each mutation by
strain combination was selected for further analysis.(c) Measuring the cost of resistance
To facilitate the competition experiments, we transformed the
ancestral genotype of each strain with a chromosomally integrated
green fluorescent protein (GFP). These strains were generated
by integrating a constitutively expressed GFP marker at the
chromosomal tn7 insertion site using the methods of Choi &
Schweizer [21]. Fitness costs were measured by competing rifam-
picin-resistant mutants against the appropriate GFP-tagged
rifampicin-sensitive ancestral strain. Competitions took place in
200 ml of KB medium in a 96-well plate, incubated at 308C with
constant shaking at 250 r.p.m. Competitions lasted 24 h. Each com-
petition was replicated six times, with the replicates of each
competition spread across at least two separate occasions. For
each competition, cells were grown overnight in KB medium.
Each mutant was then mixed 50 : 50 by volume with the GFP-
tagged ancestor, and this mixture was then diluted 10 000-fold.
Initial and final ratios of GFP-tagged to untagged cells were deter-
mined using BD C6 flow cytometer. 10 000 cells per culture were
counted and scored as either fluorescently tagged or not. Fitness
was calculated at the ratio of the number of doublings of the rifam-
picin-resistant mutant compared with the GFP-tagged ancestral
strain. To control for the cost of GFP-expression, fitness was stan-
dardized relative to the fitness of the unmarked ancestor in
competition with the GFP-tagged ancestor.(d) Correcting for phylogenetic distance
Using a selection of strains from across a genus results in potentially
confounding any results with the effects of phylogeny. Specifically,
the hierarchical nature of most phylogenies results in not all tips of a
phylogeny being equally independent from each other. For
example, in a phylogeny of three species, unless the phylogeny is
a star configuration, two strains must be more closely related to
each other than to the third strain. If a trait has any phylogenetic
correlation or bias, then it would be pseudo-replication to consider
all three strains equally independent. The method of Felsenstein
[22] overcomes this issue by first comparing the phenotypes of
the two closely related species, and then comparing the phenotype
of the third species with the average of the first two species.
The analysis across phylogenies can be further conflated as not
all evolutionary distances within a phylogeny are likely to be
equal. This latter point could have important consequences for
the influence of genetic background on the effects of a mutation,
as it would seem intuitive that differing fitness effects are less
likely between closely related strains. To control for this, we correct
for the topological effects of phylogeny using the method of
Felsenstein [22]. However, as we wished to test the effects of
evolutionary distance on the effects of a mutation, we do not stan-
dardize our contrasts by evolutionary distance as in the
conventional Felsenstein approach. We would therefore expect a
positive correlation between evolutionary distance and the size
of a contrast, assuming the probability of a mutation having
conserved effects is greater between closely related strains.
The phylogeny of this study system has been previously




3genes taken from 28 fully sequenced Pseudomonas genomes. It is a
maximum-likelihood phylogenetic tree assuming a GTR þ G þ I
model in PHYML [23]. From this phylogeny, we trimmed it to
just the eight strains used here, from which we extracted the rel-
evant evolutionary distances for each pair of strains, or a strain
and a node, or two nodes, as appropriate.
(e) Measuring gene expression per mutant
To estimate the effect of the rpoB mutations on transcriptional effi-
ciency, we use the luciferase report gene system to measure gene
expression [20]. In bacteria, transcription and translation are
strongly coupled; therefore, gene expression should provide a
good proxy for transcriptional efficiency. To measure the effects
of rpoB mutations on transcriptional efficiency, strains were
transformed with an IPTG-inducible luciferase reported gene
(henceforth lux-transformed). The luciferase gene, which reacts
with ATP to produce light, is commonly used to measure trans-
criptional activity by measuring the amount of light produced
per cell. This was performed for the three most genetic tractable
strains, specifically the ancestral strain for P. aeruginosa PAO1,
P. putida KT2440 and P. fulva CCUG12573, as well as seven
mutations common to these three strains. For each strain, overnight
cultures of the lux-transformed ancestor and each of the lux-
transformed mutants were grown in KB medium. Cultures
were then diluted 10 000-fold into 200 ml of KB medium in black
96-well Costar microplates with clear bottom (Corning, USA).
The medium was supplemented with 1 mM IPTG to induce lucifer-
ase production. The plate was then incubated in a Synergy 2
microplate reader (BioTek, USA) at 308C, during which lumines-
cence emission (RLU) per OD600 was measured every 20 min
with shaking prior to each read. Each assay was replicated on
four separate occasions.
To estimate transcriptional efficiency, the mean light produced
per bacterial cell was calculated at each time point by dividing the
luminescence of each well (in RLU) by its absorbance (OD600). The
maximum gradient of each RLU/OD600 curve was then calculated
using nine consecutive data points during the early exponential
phase. Within each assay, the relative lux expression rate in each
rpoB mutant strain was obtained by normalizing each gradient to
that of the ancestral strain control in the same plate. This provides
a measure of the maximum rate of transcription per mutant.3. Results
(a) Fitness costs of rifampicin resistance across species
of Pseudomonas
To estimate the relative importance of genetic background in
determining the fitness cost of rifampicin resistance, we per-
formed competitive fitness assays on a previously generated
collection of rifampicin-resistant mutations from eight strains of
Pseudomonas. Each of the competition experiments for the 161
unique strain-by-mutation combinations were replicated six
times, giving 966 independent fitness measurements (figure 1).
As shown, there is considerable variation in the cost of resistance.
Owing to the low number of mutations common to all strains, as
well as the high number of mutations found in only one strain,
we analysed these data using a model consisting of just the
main effects of strain and mutation. We find that although
both factors significantly affect the cost of resistance (strain:
F7,876¼ 8.79, p , 0.001; mutation: F51,876¼ 8.34, p , 0.001),
mutation explains a greater proportion of the variation in fitness
(mutation¼ 27.1% of variance; strain¼ 4.0% of variance). How-
ever, even if there is greater variance between mutations than
strains, genetic background could still be affecting the costof resistance. To test how commonly the cost of a mutation
depended on its genetic background, we performed Bonferroni-
corrected one-way ANOVAs on every mutation which arose in
at least two backgrounds. Of these 33 comparisons, 14 (42.2%)
are significant at the Bonferroni-corrected p-value of 0.0015,
demonstrating that genetic background impacts fitness for
almost half of these mutations under aconservative statistical test.
An alternative approach to estimate the effects of epistasis
is to limit the analysis to just the four mutations common to
all eight strains (figure 2). Although this limits the scope of
the analysis, this approach makes it possible to estimate the
contribution of the interaction between mutation and genetic
background to the cost of a mutation. This analysis reveals
significant effects of mutation (F3,158 ¼ 7.53, p , 0.001) and
genetic backgrounds (F7,158 ¼ 7.13, p , 0.001) on fitness,
and an interaction between mutation and genetic background
(F21,158 ¼ 7.37, p , 0.001). However, the proportion of var-
iance explained by mutation is small (5.83%), whereas the
explanatory power of genetic background is not much greater
(12.88%). In contrast, the interaction term explains 39.92% of
the variance. The implication of this result is that the inter-
action between a rifampicin resistance mutation and the
genetic background plays a dominant role in determining
the cost of resistance. Intriguingly, this epistatic interaction
is driven by a complex interplay between mutations and gen-
etic backgrounds, and not because all mutations are more
costly in some strains than others.(b) Phylogeny and the costs of a mutation
One important assumption of the above analyses is that they
do not take phylogeny into account, and this may be an
important bias. For example, intuition suggests that a
mutation is more likely to have more similar effects on fitness
in two closely related strains than in two distantly related
strains. To test the hypothesis that phylogenetic distance
drives epistasis, we tested for a positive correlation between
genetic distance and epistasis using methods based on phylo-
genetically independent contrasts (PICs). As in PICs, we
calculated the difference between neighbouring tips or
nodes, thereby controlling for unequal relatedness between
differing species (figure 3a). However, rather than standar-
dize these contrasts by dividing by the underlying genetic
distance, we looked for a relationship between genetic distance
and the size of a contrast. If a mutation was found in all eight
strains, it is possible to make seven contrasts. Because not all
mutations were found in all strains, from the 33 mutations
which were found in more than one strain it is possible to
make 109 contrasts (figure 3b). We found no significant
relationship between evolutionary distance and epistasis
(Pearson’s correlation: r ¼ 20.480, d.f.¼ 107, p ¼ 0.878). To
see if evolutionary distance increases the probability of epista-
sis for any individual mutations, we re-analysed the data for
the four mutations common to all strains, as these would
have the most statistical power. None of the four show a
significant correlation between evolutionary distance and
epistasis (A1553G: r ¼ 20.480, d.f. ¼ 5, p ¼ 0.275; A1562G:
r ¼ 20.379, d.f.¼ 5, p ¼ 0.402; C1591T: r ¼ 20.449, d.f. ¼ 5,
p ¼ 0.312; A1592G: r ¼ 20.619, d.f. ¼ 5, p ¼ 0.138). In short,
mutations do not appear to have similar effects on fitness
between more closely related strains. Therefore, at this scale,
it appears that phylogenetic relatedness is not an important



































































































































Figure 1. Fitness effects of resistance mutations across species. Numbers show the fitness of rifampicin-resistant mutants relative to their respective ancestral strains in the
absence of antibiotics, such that a value of 1 represents equal fitness. Each competition assay was carried out with sixfold replication and the colours highlight variation in





(c) Molecular mechanisms underpinning cross-strain
epistasis
Previous work has shown that compromised transcriptional
efficiency explains much of the variation in the fitness cost
of rifampicin resistance in P. aeruginosa [20], providing apotential molecular mechanism to explore the cost of resist-
ance across strains. To link transcriptional efficiency with
fitness, we transformed clones of P. aeruginosa PAO1,
P. putida KT2440 and P. fulva CCUG12573 with a chromoso-
mally integrated reporter that measures transcriptional




























Figure 2. Epistastic effects of rifampicin resistance mutations on fitness across Pseudomonas. The fitness effect of the four common rifampicin resistance mutations
across eight strains of Pseudomonas (+s.e.m; n ¼ 6) is shown. The fitness of each resistant mutant was measured relative to its ancestor in the absence of















































Figure 3. Evolutionary divergence does not predict epistasis. (a) Phylogeny of the eight ancestral strains of Pseudomonas. Branch lengths are proportional to
evolutionary distance. (b) The contrast in the fitness effect of rifampicin resistance mutations between tips or nodes on the phylogeny shown as a function of
evolutionary distance. We find no evidence that rifampicin resistance mutations have more divergent effects on fitness between distantly related bacterial strains





genetic transformation, and the same seven rpoB mutations
were transformed in each strain.
Given that transcriptional efficiency is likely to be an impor-
tant determinant of fitness across strains, two mechanismscould explain why resistance mutations have background-
dependent effects on fitness. First, it is possible that the same
mutation has different effects on transcriptional efficiency in
















































Figure 4. Linking epistasis to transcriptional efficiency. (a) The transcriptional efficiency (+s.e.m; n ¼ 6) of seven rifampicin resistance mutations in P. putida
KT2440, P. aeruginosa PAO1 and P. fulva CCUG12573. (b) The correlation between relative fitness and transcriptional efficiency for the seven mutations common to
these three strains. Transcriptional efficiency and fitness were independently assayed relative to the ancestral strains, such that a value of 1 denotes fitness or





transcriptional efficiency is significantly affected by mutation
(figure 4a; F6,63¼ 49.61, p , 0.001, variance explained¼
37.5%), strain (figure 4a; F2,63¼ 105.54, p , 0.001, variance
explained ¼ 26.6%) and, crucially, an interaction between
strain and mutation (figure 4a; F12,63 ¼ 18.48, p , 0.001,
variance explained ¼ 28.0%). In other words, the same
rifampicin resistance mutation has different effects on tran-
scriptional efficiency in different strains of Pseudomonas,
resulting in epistatic interactions for fitness between resistance
mutations and genetic background. Second, it is possible that
even when resistance mutations have consistent effects on
transcriptional efficiency across strains, compromised tran-
scriptional efficiency carries a greater cost in some strains
than others. To test if the relationship between transcription
and fitness is strain-dependent, we analysed the fitness
of these 21 transformed mutants using a general linear
model with transcription rate fitted as a covariate and strain
fitted as a fixed factor. As expected (figure 4b), we find that
transcriptional efficiency significantly correlates with fitness
(transcription: F1,15¼ 12.3, p , 0.005, variance explained
¼ 45.1%). This correlation is not significantly affected bystrain (F2,15 ¼ 0.45, p ¼ 0.645, variance explained ¼ 5.7%), nor
by an interaction between strain and transcription rate
(F2,15 ¼ 0.37, p ¼ 0.697, variance explained ¼ 4.7%), demon-
strating that the relationship between transcriptional
efficiency and fitness is constant across strains.4. Discussion
Although genetic background is increasingly being seen as
an important influence on adaptation (reviewed in [24,25]),
experimental estimates of its role remain rare. Here we demon-
strate that epistatic interactions between antibiotic resistance
mutations and the genetic backgrounds in which they evolve
are key in determining the fitness costs of rifampicin resistance.
Given that fitness costs have a central role in the long-term
dynamics of resistance, genetic background is likely to play a
key role in the evolution of resistance. Specifically, we find
that the fitness effects of over 40% of rifampicin resistance
mutations differ significantly between species of Pseudomonas.




7compromised transcriptional efficiency plays a key role in
determining the cost of rifampicin resistance. Moreover, the
relationship between transcriptional efficiency and fitness is
constant across strains, and the epistatic effects of rifampicin
resistance on mutations arise from the fact that mutations
have background-specific effects on transcriptional efficiency.
In other words, in this system the relationship between pheno-
type (transcriptional efficiency) and fitness is constant over the
range of tested values, but the phenotypic effect of mutations is
complex and strain-specific.
One feature of the design of our study is that we tested
for background effects at quite a broad phylogenetic scale.
Pseudomonas is a genus that is well known for its remarkable
phenotypic and genetic diversity [14]. The strains used in this
study were selected to sample a broad range of this diversity
without sacrificing the experimental tractability that is
required to accurately measure the fitness costs of resistance.
From our data, it is clear that genetic background has a per-
vasive impact on the cost of resistance at this phylogenetic
scale. However, our study does not provide any insights
into whether this is likely to be the case at a finer phylogenetic
scale, such as different clones from the same species. Although
there is almost certainly less diversity within any one species
than observed between our isolates from many different
species, this is not to say there is considerable genomic diver-
sity within species of bacteria [26–28]. Equally, the cost of
resistance has been shown to be epistatic even when strains
only vary by as little as a single mutation [11,12]. Taken
together, there is no reason why genetic background effects
cannot also be as pronounced as observed here at considerably
smaller evolutionary scales.
The cost of antibiotic resistance is predicted to be crucial
to the clinical evolutionary dynamics of resistance [1,2].
As genetic background strongly affects the cost of resistance,
this may explain why certain lineages of pathogen species are
more likely to be epidemic than others [29]. The explanation
for these so-called dominant or epidemic strains is often the
possession of specific traits, such as particular antibiotic
resistance determinants or virulence factors. But this leads
to the question of why these strains have successfully
acquired these traits, but other clones have not. Although
there are several potential reasons, one interpretation is that
these genetic backgrounds are the ones where these traits
possess the lowest cost. This raises the important point that
the function and cost of clinically important traits measured
on a particular (often laboratory-adapted) strain should be
assumed to be identical for all strains and clones.
In our experiment, we investigated only the relationship
between fitness and transcription in a single environment.
However, not only do clinical populations of bacteria encoun-
ter many different environments, but the cost of antibiotic
resistance has been shown to be environment-dependent
[30]. It is unlikely that transcription will be equally correlated
with fitness across all possible environments. Indeed, it has
been previously shown that the costs of rpoB mutations are
reduced when the need for transcription is artificially lowered
[31]. Therefore, in some environments (or rather in some com-
binations of environments and genetic backgrounds) the
relationship between transcription and fitness will disappear.
However, the relationship between transcription and fitness
in chronic Mycobacterium tuberculosis infections is likely to
be strong. Using rifampicin to treat M. tuberculosis is
rifampicin’s most common clinical use, and consequentlymany M. tuberculosis populations evolve resistance to rifampi-
cin via mutations in rpoB [6,32]. These populations will often
subsequently adapt to the costs of rpoB mutations by fixing
compensatory mutations [32], which in other systems have
been shown to restore fitness by directly restoring transcrip-
tional efficiency [15,33]. Therefore, it would appear that
transcriptional efficiency is also likely to be tightly correlated
with fitness in clinical M. tuberculosis infections.
Additionally, as genetic background can significantly affect
the cost of resistance, this could have important consequences
for adaptation to the cost of resistance. Compensatory adap-
tation to the cost of antibiotic resistance is predicted to be
critical to its evolutionary dynamics [2], as it can slow or
even prevent the extinction of resistant strains in the absence
of selection for resistance. As the probability of compensatory
adaptation should depend on the cost of a mutation, genetic
background therefore has a central role in compensatory adap-
tation to the cost of resistance. Additional support for this
comes from rifampicin-resistant M. tuberculosis, which is one
of the best-characterized examples of compensatory adaptation
[32]. It has been demonstrated that some strains can compen-
sate very rapidly over the course of a few weeks. However,
other strains, possessing the exact same mutation, took more
than 2 years to compensate for this mutation, whereas yet
other strains did not show compensatory dynamics at all
[32]. Admittedly, there are other explanations for this besides
genetic background, such as adaptation to the infection
environment rather than to compensation per se. However,
it could also be that compensation is more rapid on genetic
backgrounds in which the mutation possesses the greatest cost.
Given that rpoB is highly conserved, it is surprising that the
same mutation has different effects on transcriptional effi-
ciency in different strains of Pseudomonas. However, this
is overlooking the many different and often less conserved cel-
lular systems involved in transcriptional efficiency. In support
of this argument, previous work has shown that rpoB
mutations can have highly pleiotropic effects [34–36], includ-
ing altered expression of rpoC [20], another subunit of RNA
polymerase. Therefore, alterations to the expression of other
genes involved in transcription may explain the variable
impacts of these mutations on transcriptional efficiency,
assuming the regulation of these genes is less conserved
between species than the structure of rpoB. However, we
stress that this is quite a speculative point, and further molecu-
lar work beyond the scope of this study would be required to
test this hypothesis rigorously.
In summary, we present evidence that genetic background
is a key determinant of the fitness costs of antibiotic resistance.
As such, the effect of genetic background should not be
ignored when studying the evolution and epidemiology of
bacterial pathogens.Data accessibility. Data are available from Dryad (doi:10.5061/dryad.
qn370).
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S, Rottiers S, de Mendonça R, Struelens MJ. 2008
Evolutionary relationships between sporadic and
epidemic strains of healthcare-associated
methicillin-resistant Staphylococcus aureus. Clin.
Microbiol. Infect. 14, 659 – 669. (doi:10.1111/j.1469-
0691.2008.02015.x)
30. Björkman J, Nagaev I, Berg OG, Hughes D,
Andersson DI. 2000 Effects of environment on
compensatory mutations to ameliorate costs of
antibiotic resistance. Science 287, 1479 – 1482.
(doi:10.1126/science.287.5457.1479)
31. Hall AR, Iles JC, MacLean RC. 2011 The fitness cost
of rifampicin resistance in pseudomonas aeruginosa
depends on demand for RNA polymerase. Genetics
187, 817 – 822. (doi:10.1534/genetics.110.124628)
32. Comas I, Borrell S, Roetzer A, Rose G, Malla B, Kato-
Maeda M, Galagan J, Niemann S, Gagneux S. 2012
Whole-genome sequencing of rifampicin-resistant
Mycobacterium tuberculosis strains identifies
compensatory mutations in RNA polymerase genes.
Nat. Genet. 44, 106 – 110. (doi:10.1038/ng.1038)
33. Qi Q, Toll-Riera M, Heilbron K, Preston GM, MacLean
RC. 2016 The genomic basis of adaptation to the
fitness cost of rifampicin resistance in Pseudomonas
aeruginosa. Proc. R. Soc. B 283, 20152452. (doi:10.
1098/rspb.2015.2452)
34. Gao W et al. 2013 The RpoB H481Y rifampicin
resistance mutation and an active stringent
response reduce virulence and increase resistance
to innate immune responses in Staphylococcus
aureus. J. Infect. Dis. 207, 929 – 939. (doi:10.1093/
infdis/jis772)
35. Rodriguez-Verdugo A, Gaut B, Tenaillon O. 2013
Evolution of Escherichia coli rifampicin resistance in
an antibiotic-free environment during thermal
stress. BMC Evol. Biol. 13, 50. (doi:10.1186/1471-
2148-13-50)
36. Xu J, Tozawa Y, Lai C, Hayashi H, Ochi K. 2002 A
rifampicin resistance mutation in the rpoB gene
confers ppGpp-independent antibiotic production in
Streptomyces coelicolor A3(2). Mol. Gen. Genomics
268, 179 – 189. (doi:10.1007/s00438-002-0730-1)
